Skip to content
NeuroTechGuide

Alibaba leads a $73 million round in Chinese implanted-BCI maker StairMed

StairMed's 256-channel wireless BCI and surgical robot are heading into multi-site registration trials of about 40 patients in 2026.

In briefFundingImplants

Shanghai-based StairMed has raised RMB 500 million (about $73 million) in a round led by Alibaba, with Tencent, OrbiMed, Lilly Asia Ventures and others participating. That brings its funding over the past year to about RMB 1.1 billion. StairMed’s WRS02 system is a 256-channel wireless implanted BCI placed by the company’s own surgical robot, aimed at restoring movement and speech. The company plans multi-site registration trials with about 40 patients in 2026.

Big Chinese tech firms backing invasive BCIs highlights how quickly China’s sector is scaling up.

Learn more: Microelectrode array · StairMed

Sources

Share:XLinkedInBlueskyEmail

More news